Literature DB >> 7545522

Hypercholesterolemia and endothelial dysfunction.

P D Henry1, O A Cabello, C H Chen.   

Abstract

Endothelial cells respond to hemodynamic forces with the expression of different phenotypes with disparate functional properties. At arterial bends and flow dividers, cells are relatively deprived of fluid-shear-stress-induced cell differentiation and exhibit phenotypes with increased mitotic rate, decreased intercellular contact, increased permeability for macromolecules, and the expression of molecules favoring constriction, adhesion, and thrombosis. Arterial sites covered by such cells are vulnerable to the atherogenic effects of hypercholesterolemia. A hallmark of endothelial cells exposed to hypercholesterolemia is a reduced capacity to release endothelium-derived relaxing factor. Pharmacological interventions that suppress or stimulate nitric oxide production appear to enhance or reduce the atherogenic effects of hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545522     DOI: 10.1097/00041433-199508000-00002

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  4 in total

1.  Cardiovascular and metabolic effects of Berberine.

Authors:  Flora Affuso; Valentina Mercurio; Valeria Fazio; Serafino Fazio
Journal:  World J Cardiol       Date:  2010-04-26

2.  Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway.

Authors:  J L Schwachtgen; P Houston; C Campbell; V Sukhatme; M Braddock
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

3.  MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10.

Authors:  Jibin Lin; Shaolin He; Xinghui Sun; Gregory Franck; Yihuan Deng; Dafeng Yang; Stefan Haemmig; A K M Wara; Basak Icli; Dazhu Li; Mark W Feinberg
Journal:  FASEB J       Date:  2016-06-13       Impact factor: 5.191

4.  A double-blind, placebo-controlled clinical trial to assess the effects of a combined nutraceutical on endothelial function in patients with mild-to-moderate hypercholesterolaemia.

Authors:  Valerio Pecchioli; Arrigo F G Cicero; Nazareno Lomartire; Maria P Gemmiti; Antonello Colangeli; Rosanna Germanò; Maria Pia Corsi; Giuseppe I W Germanò
Journal:  Arch Med Sci Atheroscler Dis       Date:  2020-05-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.